Immune Therapy for Breast Cancer in 2010—Hype or Hope?
Open Access
- 1 February 2011
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 18 (1) , e9-e18
Abstract
The identification of numerous breast cancer antigens has generated increasing enthusiasm for the application of immune-based therapies in breast malignancies. Although the use of monoclonal antibodies has revolutionized the “targeted therapy” of breast cancer, and the immunomodulatory effects of bisphosphonates continue to be evaluated, few studies to date have demonstrated widespread utility for other forms of immunotherapy. The present review assesses modern research and explores whether the hopes for immunotherapy can overcome the hype.Keywords
This publication has 77 references indexed in Scilit:
- An autoimmune-mediated strategy for prophylactic breast cancer vaccinationNature Medicine, 2010
- A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neuClinical Cancer Research, 2009
- A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabBreast Cancer Research and Treatment, 2008
- Combined Clinical Trial Results of a HER2/neu(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02Clinical Cancer Research, 2008
- Post-Chemotherapeutic Administration of Interleukin-12 Retards Tumor Growth and Enhances Immune Cell Function: Combination Therapy Using Paclitaxel and IL-12Cancer Investigation, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- γδ T cells for immune therapy of patients with lymphoid malignanciesBlood, 2003
- Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 geneCancer Immunology, Immunotherapy, 1993
- Interferon-alpha and gamma mediated gene responses in a human breast carcinoma cell lineBreast Cancer Research and Treatment, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987